Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director · Chairman and CEO | March 15, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,945 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 52,945 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
ICU MEDICAL INC/DE
Report date March 15, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,106 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Exercise / conversion · Acquired 17,100 · Balance 134,106 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Direct | 124,654 |
Reported balance
After 2026-03-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-15 · Tax withholding · Disposed 9,452 · Balance 124,654 F1: These Securities are Performance-based Restricted Stock Units (PRSU). |
| Common StockSEC Table I · non-derivative | Direct | 129,526 |
Reported balance
After 2026-03-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-03-15 · Exercise / conversion · Acquired 4,872 · Balance 129,526 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table I · non-derivative | Direct | 126,833 |
Reported balance
After 2026-03-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-03-15 · Tax withholding · Disposed 2,693 · Balance 126,833 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-15 · Exercise / conversion · Disposed 4,872 · Balance 0 F3: These securities are Restricted Stock Units. F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units. |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-15 · Exercise / conversion · Disposed 17,100 · Balance 0 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F5: There is neither a purchase price nor an exercise price for the PRSUs. F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 152,339 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 152,339 |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
F3: These securities are Restricted Stock Units.
F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F5: There is neither a purchase price nor an exercise price for the PRSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2018 Filed May 22, 2018 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000011 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,143 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 21:54 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,992 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000009 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 Underlying: Common Stock · 1,992 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 21:54 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000009 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,193 Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 21:54 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000009 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2018 Filed Mar 14, 2018 19:58 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 8,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000007 · edgardoc.xml · derivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,043 Underlying: Common Stock · 8,043 shares Expires 2021-03-06 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 11, 2018 Filed Feb 13, 2018 21:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 5,493 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000005 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,493 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 11, 2018 Filed Feb 13, 2018 21:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000005 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,189 Read SEC document |
| February 11, 2018 Filed Feb 13, 2018 21:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 5,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000005 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 01:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,759 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000002 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,759 Underlying: Common Stock · 3,759 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 01:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,351 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 01:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-18-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 72,026 | $58.79 Strike: $58.79 | $4,234,408.54 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,366 Underlying: Common Stock · 72,026 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 72,026 | $190.00 | $13,684,940.00 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 72,026 | $58.79 | $4,234,408.54 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,937 Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 25,769 | $58.79 Strike: $58.79 | $1,514,959.51 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · derivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,392 Underlying: Common Stock · 25,769 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 25,769 | $190.00 | $4,896,110.00 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 25,769 | $58.79 | $1,514,959.51 |
DisclosureSEC source: 0001410442-17-000010 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,680 Read SEC document |
| October 10, 2017 Filed Oct 11, 2017 21:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 5 | $58.79 Strike: $58.79 | $293.95 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,161 Underlying: Common Stock · 5 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 10, 2017 Filed Oct 11, 2017 21:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 5 | $190.00 | $950.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 10, 2017 Filed Oct 11, 2017 21:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 5 | $58.79 | $293.95 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,916 Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 2,200 | $58.79 Strike: $58.79 | $129,338.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,166 Underlying: Common Stock · 2,200 shares Expires 2024-02-24 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,000 | $191.00 | $382,000.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 200 | $190.00 | $38,000.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,911 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 21:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 2,200 | $58.79 | $129,338.00 |
DisclosureSEC source: 0001410442-17-000009 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,111 Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 27,282 | $58.79 Strike: $58.79 | $1,603,908.78 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,366 Underlying: Common Stock · 27,282 shares Expires 2024-02-24 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 27,282 | $170.00 | $4,637,940.00 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F4 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 27,282 | $58.79 | $1,603,908.78 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,193 Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 3,704 | $58.79 Strike: $58.79 | $217,758.16 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,648 Underlying: Common Stock · 3,704 shares Expires 2024-02-24 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,704 | $171.00 | $633,384.00 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F4 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 3,704 | $58.79 | $217,758.16 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,615 Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 69,014 | $58.79 Strike: $58.79 | $4,057,333.06 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,352 Underlying: Common Stock · 69,014 shares Expires 2024-02-24 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 9,854 | $173.22 | $1,706,912.84 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 to $173.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 19,114 | $171.22 | $3,272,695.26 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,765 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.00 to $171.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 40,046 | $170.53 | $6,828,936.26 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,879 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 69,014 | $58.79 | $4,057,333.06 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,925 Read SEC document |
| May 16, 2017 Filed May 19, 2017 18:58 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000007 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F1 · kind: This was a bona fide gift with no payment in consideration F1 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| March 27, 2017 Filed Apr 4, 2017 00:57 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 5,978 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000006 · edgardoc.xml · derivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,978 Underlying: Common Stock · 5,978 shares Expires 2020-03-27 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2017 Filed Apr 4, 2017 00:57 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 5,978 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000006 · edgardoc.xml · derivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,978 Underlying: Common Stock · 5,978 shares Expires 2019-12-31 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 21:10 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 12,608 | $150.00 | $1,891,200.00 |
DisclosureSEC source: 0001410442-17-000005 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,946 F1 · security: These shares of common stock were acquired on the open market. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 21:10 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 9,535 | $150.00 | $1,430,250.00 |
DisclosureSEC source: 0001410442-17-000005 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,554 F1 · security: These shares of common stock were acquired on the open market. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 23:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 589 | $150.00 | $88,350.00 |
DisclosureSEC source: 0001410442-17-000003 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,089 F1 · security: These shares of common stock were acquired on the open market. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 00:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 22,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000002 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,680 shares Expires 2017-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · derivative.exercise_date: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 00:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 11,835 | $146.10 | $1,729,093.50 |
DisclosureSEC source: 0001410442-17-000002 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,678 Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 00:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 22,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000002 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 00:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 5,493 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000002 · edgardoc.xml · derivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,493 Underlying: Common Stock · 5,493 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 00:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,476 | $145.70 | $360,753.20 |
DisclosureSEC source: 0001410442-17-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,833 Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 00:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 5,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,758 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000001 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,518 Underlying: Common Stock · 3,758 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,816 Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.